Swipe om te navigeren naar een ander artikel
Between 30 and 50 % of MS patients may prematurely discontinue disease modifying therapies. Little research has examined how to best talk with patients who have discontinued treatment against medical advice. The aim of this pilot study was to determine whether telephone counseling increases disease modifying therapy (DMT) re-initiation among nonadherent patients with multiple sclerosis (MS). Participants were eligible if they had relapsing-remitting disease, had stopped taking a DMT, and had no plan to re-initiate treatment despite a provider recommendation. Following a baseline assessment, 81 patients were randomly assigned to either five 20 min, weekly sessions of Motivational Interviewing/Cognitive Behavioral Therapy (MI-CBT) or Treatment as Usual (TAU) with brief education. At 10 weeks, patients initially assigned to TAU switched over to MI-CBT. Compared to patients in the TAU group, patients undergoing MI-CBT were significantly more likely to indicate they were re-initiating DMT (41.7 vs. 14.3 %). These significant results were replicated among patients crossing over from TAU to MI-CBT. Treatment satisfaction was high, with 97 % of participants reporting that they would recommend MI-CBT to other patients with MS. Results of this pilot study provide initial support for the use of MI-CBT among MS patients who have discontinued treatment against medical advice.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Ebers, G. C. (1998). Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group. The Lancet, 352, 1498–504. CrossRef
Gerkovich, M., Williams, K., Catley, D., & Goggin, K. (2008). Development and validation of a scale to measure motivation to adhere to HIV medication. Poster presented at the 3rd international conference on HIV treatment adherence.
Goggin, K., Gerkovich, M., Williams, K., Banderas, J., Catley, D., Berkley-Patton, J., et al. (2013). A randomized controlled trial examining the efficacy of motivation counseling with observed therapy for anti-retroviral therapy adhrence. AIDS and Behavior,17, 1992–2001. CrossRefPubMedPubMedCentral
Halpern, R., Agarwal, S., Dembek, C., Borton, L., & Lopez-Bresnahan, M. (2011). Comparison of adherence and persistence among multiple sclerosis patients treated with disease-modifying therapies: A retrospective administrative claims analysis. Patient Prefer Adherence,5, 73–84. CrossRefPubMedPubMedCentral
Miller, W., & Rollnick, S. (2013). Motivational interviewing: Helping people change (3rd ed.). New York: The Guilford Press.
Mohr, D., Boudewyn, A. C., Likosky, W., Levine, E., & Goodkin, D. E. (2001). Injectable medication for the treatment of multiple sclerosis: The influence of self-efficacy expectations and injection anxiety on adherence and ability to self-inject. Annals of Behavioral Medicine,23, 125–132. CrossRefPubMed
National Multiple Sclerosis Society. (2015a). MS prevalence [cited February 2, 2015]. http://www.nationalmssociety.org/About-the-Society/MS-Prevalence
National Multiple Sclerosis Society. (2015b). MS symptoms [cited February 2, 2015]. http://www.nationalmssociety.org/Symptoms-Diagnosis/MS-Symptoms
National Multiple Sclerosis Society. (2015c). Secondary-progressive MS (SPMS) [cited February 3, 2015]. http://www.nationalmssociety.org/What-is-MS/Types-of-MS/Secondary-progressive-MS
Parsons, J., Rosof, E., Punzalan, J., & Di Maria, L. (2005). Patient care and STDs. Aids,19, 31–39.
Pozzilli, C., Schweikert, B., Ecari, U., & Oentrich, W. (2011). Supportive strategies to improve adherence to IFN Beta-1b in multiple sclerosis—Results of the BPlus observational cohort study. Journal of Neurological Sciences,307, 120–126. CrossRef
Tullman, M. J. (2013). Overview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosis. The American Journal of Managed Care,19, S15–S20. PubMed
- A pilot study to improve adherence among MS patients who discontinue treatment against medical advice
- Springer US